Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

Clinical trial NCT05983432 · RECRUITING

Trial details

NCT number: NCT05983432
Sponsor: SystImmune Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Non Small Cell Lung Cancer Lung Cancer Breast Cancer Esophageal Cancer Small Cell Lung Cancer Nasopharyngeal Cancer Head and Neck Squamous Cell Carcinoma Prostate Adenocarcinoma Ovarian Cancer Endometrial Cancer Cervical Cancer Triple Negative Breast Cancer

Start date: 2023-08-08
Primary completion: 2026-12-31
Enrollment: 470

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.